Motorola Licenses Molecular Staging Technology; MSI Raises $41.25M | GenomeWeb

NEW YORK, Dec 19 – Motorola said Tuesday it had reached an agreement to exclusively license Molecular Staging’s Rolling Circle Amplification Technology for use in its diagnostic nucleic acid bioarrays, marking Motorola’s fourth genomics collaboration as it attempts to gain a foothold in the burgeoning market.

In exchange for the technology, Motorola will pay a licensing fee as well as make equity investments in Molecular Staging. Motorola also received an option to increase its stake in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.